12:50 PM EDT, 05/31/2024 (MT Newswires) -- Verve Therapeutics ( VERV ) said Friday it has named Troy Lister as chief scientific officer, starting June 21.

Lister, presently senior vice president of research and early development at the company, will replace Andrew Bellinger, who is stepping down but will continue to serve in an advisory capacity, the company said.

Price: 5.13, Change: -0.01, Percent Change: -0.19